downsides of glp 1 Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks Your guide to GLP-1 side

Women in the study who were obese and taking GLP-1 weight loss medications were 30% less likely to develop breast cancer than other women.

For individuals on GLP-1 medications like Ozempic, Wegovy, or Mounjaro, having the right app to complement your health journey is crucial

Patients taking Ozempic and Wegovy say their hair is starting to fall out

According to PharmaTrac data., Mounjaro launched in March last year, added Rs.105 crore in December, taking its total sales to Rs.600 crore in sales, reflecting rapid uptake despite hardly any insurance coverage and outofpocket affordability constraints.

In a recent study, researchers found that GLP-1RA medications such as Ozempic and Wegovy are associated with a higher risk of post-endoscopy aspiration pneumonia.